Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 1c, raises guidance

Zimmer Biomet Holdings (NYSE: ZBH) reported Q2 EPS of $1.82, $0.01 better than the analyst estimate of $1.81. Revenue for the quarter came in at $1.87 billion versus the consensus estimate of $1.82 billion.

Guidance:

Adjusted Diluted EPS in the range of $7.47 - $7.57

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00
• Schwab's May activity shows margin loans nearly double